Greg Duncan's Insider Trades & SAST Disclosures
Greg Duncan's most recent trade in CorMedix Inc was a trade of 25,000 Common Stock done . Disclosure was reported to the exchange on Jan. 17, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Greg Duncan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CorMedix Inc | Gregory Duncan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 25,000 | 25,000 (0%) | 0% | 0 | Common Stock | |
| CorMedix Inc | Gregory Duncan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| Dogwood Therapeutics Inc. | Gregory Duncan | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 138,835 | 138,835 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | Gregory Duncan | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 17 Aug 2023 | 25,000 | 57,461 | - | 1.2 | 31,245 | Common Stock |
| CorMedix Inc | Gregory Duncan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| Dogwood Therapeutics Inc. | Greg Duncan | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2022 | 410,000 | 410,000 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | Greg Duncan | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | Greg Duncan | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 4.52 per share. | 23 May 2022 | 7,500 | 32,461 | - | 4.5 | 33,900 | Common Stock |
| CorMedix Inc | Greg Duncan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| Dogwood Therapeutics Inc. | Greg Duncan | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 5.52 per share. | 21 Dec 2021 | 5,000 | 24,961 | - | 5.5 | 27,615 | Common Stock |
| Dogwood Therapeutics Inc. | Greg Duncan | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2021 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | Greg Duncan | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.36 per share. | 06 Apr 2021 | 382 | 19,961 | - | 6.4 | 2,429 | Common Stock |
| Dogwood Therapeutics Inc. | Greg Duncan | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.17 per share. | 05 Apr 2021 | 15,675 | 19,579 | - | 6.2 | 96,757 | Common Stock |
| Dogwood Therapeutics Inc. | Greg Duncan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 21,796 | 435,921 | - | - | Stock Option (right to buy) | |
| CorMedix Inc | Greg Duncan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| Dogwood Therapeutics Inc. | Greg Duncan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 801 | 0 | - | - | Warrant to Purchase Common Stock | |
| Dogwood Therapeutics Inc. | Greg Duncan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 06 Jan 2021 | 801 | 3,904 | - | 7.8 | 6,248 | Common Stock |
| Dogwood Therapeutics Inc. | Greg Duncan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 414,125 | 414,125 | - | - | Stock Option (right to buy) | |
| CorMedix Inc | Greg Duncan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Greg Duncan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 2,500 | 2,500 | - | - | Stock Option (Right to Buy Common Stock) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges